Innovation Pharmaceuticals Inc (IPIX)

[BioTechMaven]

And a double victory in primary and secondary followed by FDA breakthrough designation would further validate the notable successes from Brilacidin’s IBD and ABSSSI phase 2 and phase 2B trials, while likely also establishing Brilacidin OM om track to become the World first approved preventative OM treatment in a billion dollar market, with endless patients in need, desperate for a drug that works.

While you dream of big bank accounts, never forget the dire need for an OM drug that actually WORKS.

Trial success, will imo, certainly bring breakthrough designation and likely a nice partner, while again, further validating Brilacidin in many indications and marking the arrival of Brilacidin into the limelight.

Kevetrin and Prurisol lurk too. And i would really love to see and IBD deal in 2018. If you look at the success with absssi and possibly in OM, any smart pharma will likely be saying, “gee Whitaker, this drug nailed a 215 Patient 2B, showed remarkable data in a Phase 2 pOc, and...OM?

There are companies in the OM space that are only that, in the OM space, with market cap many multiples higher than ipix.

Will a confirmatory watershed moment soon arrive? I’m tuned in and ready.

A trial fail in OM would be very harsh though for the company, and I don’t want to predict or think about that, but a trial success, and you have an entire drug platform validated in a nano second with exciting times ahead.

Good luck to all.